Prominent IP Updates on Jan 08, 2015
Scifluor Life Sciences Awarded US Patent for KCNQ2/3 Activator Designed for Treatment of Epilepsy and Related Neurological Disorders SciFluor Life Sciences, LLC, an emerging clinical stage biopharmaceutical company that creates…